SecBot SecBot
Insider Cluster (2 insiders) ·Filed May 29, 2026

NBIX

NEUROCRINE BIOSCIENCES INC
NEUTRAL
Impact 3/10
Horizonweeks Processed5mo ago
Insider cluster: 2 insiders, $2.3M total
Actionable Insight • Neutral

The sales are routine post-acquisition liquidity events, not a bearish signal. The CSO's sale was fully hedged by derivative exercises (zero net economic exposure change). Director grants are standard compensation. No follow-up action warranted, monitor next 10-Q for integration progress on Soleno's VYKAT XR.

DirectionNeutral
Confidencehigh
Horizonweeks

How the stock moved after the report

NEUTRAL VIEWSTOCK BELOW ENTRY AT T+60
Entry
$160.48
T+0 close · May 29, 2026 · via day close
Latest settled
−4.79%
T+60 · $152.80
Vs SPY
−5.76%
α at T+60
Horizons
All settled
through T+60
  1. T+0 · Jun 1 $160.48entry
  2. T+1 · 6mo ago −3.55%α −3.70% · $154.78
  3. T+5 · 5mo ago +2.12%α +4.87% · $163.88
  4. T+20 · 5mo ago +5.94%α +8.25% · $170.00
  5. T+60 · 3mo ago −4.79%α −5.76% · $152.80

Price Chart

Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

Two Neurocrine executives sold shares totaling $2.32M in the week following the close of the $2.9B Soleno acquisition. The CSO's sale of $1.71M was paired with a derivative exercise, while the Chief Corp. Affairs Officer sold $609K. Director grants on May 27 are non-cash compensation and carry no economic signal. The sales represent ~0.015% of market cap, well below the 0.1% materiality threshold, and are likely liquidity-driven following the acquisition close.

Key Financial Metrics

Direction
selling
Total Value
$2.3M
Insiders
2

Key Facts

  • CSO Onyia Jude sold 11,000 shares at $155.53 for $1.71M on May 27, paired with derivative exercises (11,000 shares at $0 and 11,000 shares at $84.74)
  • Chief Corp. Affairs Officer Boyer sold 3,888 shares at $156.64 for $609K on May 26
  • Total open-market sales: $2.32M, representing ~0.015% of NBIX's $15.7B market cap
  • 11 directors received non-cash stock grants on May 27 totaling ~29,000 shares at $0, routine compensation, no economic signal
  • Sales occurred 9 days after the May 18 close of the $2.9B Soleno acquisition

Financial Impact

Total insider sales of $2.32M represent ~0.015% of market cap, immaterial relative to company size

dilution

Risk Factors

  • Post-acquisition integration risk for Soleno's VYKAT XR (Prader-Willi syndrome) could pressure near-term earnings
  • Additional $600M drawn on $1.0B credit facility increases leverage, though manageable for a $15.7B market cap company

Market Snapshot

Exchange
Nasdaq
Sector
Biological Products, (No Diagnostic Substances)
Analyst Consensus
86% bullish (35 analysts)

Investment Themes

Documents Analyzed

This report is based on 1 SEC document filed with EDGAR.

DocumentAccession Number
CLUSTER Data (Synthetic)cluster-NBIX-1780092662734

Track record

30 reports on NBIX

Performance horizon

3 of 4 bullish or bearish reports moved the stock their way by T+20. Best: +27.40% at T+60 after the Apr 6, 2026 report. 5 of 5 went positive at some point.

Filters
  1. Nov 10, 20266d ago 144 Neutral 2/10 Entry $174.41 Now $165.31 −5.22% settles Dec 10
  2. Nov 10, 20267d ago PTAB Trial Neutral 3/10 Entry $169.14 Now $165.31 −2.26% settles Dec 9
  3. Nov 10, 20267d ago PTAB Trial Neutral 3/10 Entry $169.14 Now $165.31 −2.26% settles Dec 9
  4. Nov 10, 20267d ago PTAB Trial Neutral 3/10 Entry $169.14 Now $165.31 −2.26% settles Dec 9
  5. Nov 2, 202614d ago Press Release Bullish 6/10 No price data
  6. Nov 2, 202614d ago 144 Neutral 2/10 Entry $164.85 Now $165.31 +0.28% settles Dec 2
  7. Nov 2, 202614d ago 8-K Bullish 6/10 Entry $164.85 Now $165.31 +0.28% settles Dec 2
  8. Oct 30, 202617d ago 144 Neutral 1/10 Entry $145.35 Now $165.31 +13.73% settles Dec 1
  9. Oct 30, 202617d ago SC 13G Neutral 3/10 Entry $146.10 Now $165.31 +13.15% settles Nov 30
  10. Oct 27, 202620d ago Institutional Cluster Mixed 3/10 Entry $145.53 Now $165.31 +13.59% settles Nov 25
Showing 10 of 30

US Market Status

Market Closed · Opens in 8h 34m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published May 29, 2026